Worldwide Nasal Cannula Industry to 2028 - Featuring Teleflex, Vapotherm and Well Lead Medical Among Others

News provided by

Feb 17, 2022, 06:45 ET

DUBLIN, Feb. 17, 2022 /PRNewswire/ -- The "The Nasal Cannula Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The nasal cannula device is used to deliver oxygen to patients with respiratory diseases such as asthma, lung cancer, pneumonia, Chronic Obstructive Pulmonary Diseases (COPD), and pulmonary fibrosis.

This device is made up of plastic or silicon material and has a tube-like structure with two prongs to connect nostrils for providing oxygen. These tubes are placed behind the ear to allow for better adjustment of the prongs. These nasal cannula tubes are available at a low cost, which drives the growth of the nasal cannula market. There are different types of nasal cannulas available in the market which are used for pre-mature infants, adults suffering from respiratory diseases, patients with lung cancer, or patients with respiratory failure due to COVID-19.

Market Dynamics

Market players are indulged in inorganic activities such as collaborations in order to increase research and development activities for the treatment of respiratory diseases. This is expected to increase the growth of the global nasal cannula market over the forecast period. For instance, on February 17, 2021, Vir Biotechnology and GSK expanded their coronavirus collaboration to develop advanced therapeutics for influenza and respiratory viruses. Vir Biotechnology is immunology focused company aims for developing technologies for infectious diseases and GSK is manufacturer of vaccines, innovative medicines and healthcare products. The aim of this collaboration is to use Vir's monoclonal antibody technology to create an identical new anti-viral antibodies for therapeutic treatments and preventions for COVID -19 or future outbreaks of the pathogenic diseases.

Increasing awareness for the treatment as well as management of respiratory diseases is expected to increase the growth of the global nasal cannula market over the forecast period. For instance, a news published on September 9, 2021 by AstraZeneca is a global pharmaceutical business company and manufacturer of innovative medicines has launched program called as International Respiratory Coalition for Urgent need for national respiratory strategies after COVID-19 to drive the improvements in healthcare systems resilience. It is coordinated with European Respiratory Society .This program will provide funding or contribution with expertise for delivering facilities to patients suffering for respiratory diseases.

Key features of the study:

This report provides an in-depth analysis of global nasal cannula market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global nasal cannula market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Medtronic plc., Maquet Holding B.V. & Co. KG, Edward LifeSciences Corp., Terumo Corporation, Sorin Group, Medin Medical innovations, Flexicare Medical, Smiths Medical, Teleflex Incorporated, Vapotherm Inc., Salter Labs, Well Lead Medical Co. Ltd., Drive Devilbiss International, Allied Healthcare Products, Besmed Health Business Corp. and Fairmont Medical.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global nasal cannula market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal cannula market

Key Topics Covered:

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Material
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Regulatory Scenario
PEST Analysis
Recent Product Launch/Approval
Epidemiology
Mergers and Acquisitions

4. COVID - 19 Impact Analysis

Impact on Supply Chain
Impact on Research and Development
Government Initiatives

5. Global Nasal Cannula Market, By Product Type, 2017-2028 (US$ Million)

Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 - 2028
Segment Trends
Curved prong cannula
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Flared prong cannula
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Straight prong cannula
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Curved and flared prong cannula
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Nasal Cannula Market, By Material, 2017-2028 (US$ Million)

Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 - 2028
Segment Trends
Plastic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Silicon
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Nasal Cannula Market, By Application , 2017-2028 (US$ Million)

Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 - 2028
Segment Trends
Asthma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Lung cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Chronic bronchitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Pulmonary embolism
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
COPD
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Emphysema
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Cystic fibrosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Pneumonia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Nasal Cannula Market, By End User, 2017 - 2028 (US$ Million)

Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 - 2028
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Long term care center
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Home care settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Ambulatory surgical centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

9. Global Nasal Cannula Market, By Region, 2017 - 2028 (US$ Million)

Introduction
Market Share Analysis, By Region, 2021 and 2028 (%)
Y-o-Y Growth Analysis, For Regions, 2018 - 2028
Regional Trends
North America
Market Size and Forecast, By Product Type , 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Material , 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User , 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Product Type , 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Material , 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User , 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Material, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Material, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Material, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Material, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By End User , 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
South Africa
Central Africa
North Africa

10. Competitive Landscape

Company Profiles
Medtronic plc.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Maquet Holding B.V. & Co. KG
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Edward LifeSciences Corp.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Terumo Corporation
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Sorin Group
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Medin Medical innovations
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Flexicare Medical
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Smiths Medical
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Teleflex Incorporated
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Vapotherm Inc.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Salter Labs
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Well Lead Medical Co. Ltd.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Drive Devilbiss International
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Allied Healthcare Products
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Resmed Health Business Corp.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Fairmont Medical
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Strategies

11. Section

For more information about this report visit https://www.researchandmarkets.com/r/387yxg

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets